HUTCHMED (China) (HMDCF) Depreciation & Amortization (CF) (2015 - 2016)
HUTCHMED (China) (HMDCF) reported Depreciation & Amortization (CF) of -$1.5 million for Q2 2016, down 182.84% year-over-year from $1.8 million in Q3 2015, and down 182.84% quarter-over-quarter from $1.8 million in Q2 2015.
HUTCHMED (China) (HMDCF) Depreciation & Amortization (CF) (2015 - 2016) Analysis & Trends
HUTCHMED (China) (HMDCF) has 2 years of Depreciation & Amortization (CF) data on file, last reported at -$1.5 million in Q2 2016.
- Depreciation & Amortization (CF) for Q2 2016 came in at -$1.5 million, down 182.84% year-over-year; the trailing twelve-month figure through Dec 2017 was -$1.5 million (down 582.69% YoY), and the FY2025 annual result was $13.3 million, up 7.84% from the prior year.
- Depreciation & Amortization (CF) slipped to -$1.5 million in Q2 2016 per HMDCF's latest filing, from $1.8 million in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $1.8 million in Q2 2015 and troughed at -$1.5 million in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 239.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 119.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 22.60 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 7.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 172.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 19.43 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 21.95 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 22.68 Mn |
| 10 | HUTCHMED (China) | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | -1.51 Mn |
| Jun 30, 2016 | -1.51 Mn |
| Jun 30, 2015 | 1.82 Mn |
| Jun 30, 2015 | 1.82 Mn |